Reduced versus standard intradetrusor OnabotulinumtoxinA injections for treatment of overactive bladder-Reference-Cited by-同舟云学术

Reduced versus standard intradetrusor OnabotulinumtoxinA injections for treatment of overactive bladder

Published:2022-12 Issue:1 Volume:42 Page:366-374
ISSN:0733-2467
Container-title:Neurourology and Urodynamics
language:en
Short-container-title:Neurourology and Urodynamics

Author:

DiCarlo‐Meacham Angela M.¹²^ORCID,Dengler Katherine L.²,Welch Eva K.²,Brooks Daniel I.³,Gruber Daniel D.²⁴,Osborn David J.⁵⁶,Scarlotta Leah²⁷,Vaccaro Christine M.²

Affiliation:

1. Department of Gynecologic Surgery and Obstetrics Naval Medical Center San Diego San Diego California USA

2. Department of Obstetrics and Gynecology Walter Reed National Military Medical Center Bethesda Maryland USA

3. Department of Research Programs Walter Reed National Military Medical Center Bethesda Maryland USA

4. Department of Urogynecology Sibley Memorial Hospital Washington District of Columbia USA

5. Department of Urology Walter Reed National Military Medical Center Bethesda Maryland USA

6. Department of Urology Chesapeake Urology Associates Germantown Maryland USA

7. Department of Obstetrics and Gynecology General Leonard Wood Army Hospital Fort Leonard Wood Missouri USA

Publisher

Wiley

Subject

Urology,Neurology (clinical)

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/nau.25107

Reference25 articles.

1. How widespread are the symptoms of an overactive bladder and how are they managed? A population-based prevalence study

2. The Burden of Overactive Bladder on US Public Health

3. Real life persistence rate with antimuscarinic treatment in patients with idiopathic or neurogenic overactive bladder: a prospective cohort study with solifenacin

4. Persistence of antimuscarinic drug use

5. Effectiveness and persistence of mirabegron as a first‐line treatment in patients with overactive bladder in real‐life practice

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Challenges and practical considerations in delivering botulinum neurotoxin to adults with congenital neurogenic lower urinary tract dysfunction with history of genitourinary reconstruction;Continence Reports;2024-09

2. Efficacy, Satisfaction, and Compliance: Insights from 15 Years of Botulinum Toxin Use for Female Urgency Urinary Incontinence;Toxins;2024-07-26

4. Antibiotics for UTI Prevention After Intradetrusor OnabotulinumtoxinA Injections;Urogynecology;2024-03

5. Injection site number and outcomes of intradetrusor onabotulinumtoxinA for refractory overactive bladder syndrome: a randomized clinical trial;International Urogynecology Journal;2023-11-22